EcoR1 Capital as of Sept. 30, 2016
Portfolio Holdings for EcoR1 Capital
EcoR1 Capital holds 31 positions in its portfolio as reported in the September 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ironwood Pharmaceuticals (IRWD) | 13.7 | $45M | 2.8M | 15.88 | |
| Galapagos Nv- (GLPG) | 9.9 | $32M | 501k | 64.66 | |
| Bristol-myers Squibb | 8.3 | $27M | 500k | 53.92 | |
| Assembly Biosciences | 6.5 | $21M | 2.9M | 7.21 | |
| Dermira | 5.4 | $18M | 522k | 33.82 | |
| Ardelyx (ARDX) | 5.2 | $17M | 1.3M | 12.94 | |
| Kura Oncology (KURA) | 5.0 | $16M | 2.6M | 6.25 | |
| Five Prime Therapeutics | 4.6 | $15M | 287k | 52.49 | |
| Fibrogen (FGEN) | 4.4 | $14M | 686k | 20.70 | |
| Gilead Sciences Inc option | 3.6 | $12M | 150k | 79.12 | |
| Allergan Plc call | 3.5 | $12M | 50k | 230.32 | |
| Agios Pharmaceuticals (AGIO) | 3.2 | $11M | 200k | 52.82 | |
| Proteostasis Therapeutics In | 2.9 | $9.4M | 602k | 15.59 | |
| Exact Sciences Corp. cmn | 2.9 | $9.3M | 500k | 18.57 | |
| Achaogen | 2.5 | $8.0M | 1.7M | 4.79 | |
| Cytokinetics (CYTK) | 2.4 | $7.8M | 847k | 9.18 | |
| Kindred Biosciences | 2.2 | $7.1M | 1.4M | 4.99 | |
| Syndax Pharmaceuticals (SNDX) | 1.7 | $5.4M | 357k | 15.16 | |
| Beigene (BGNE) | 1.6 | $5.0M | 164k | 30.81 | |
| Ironwood Pharmaceuticals Inc cl a | 1.4 | $4.5M | 282k | 15.88 | |
| Ascendis Pharma A S (ASND) | 1.4 | $4.4M | 219k | 20.10 | |
| Spark Therapeutics | 1.3 | $4.1M | 69k | 60.06 | |
| Nabriva Therapeutics | 1.2 | $3.9M | 549k | 7.05 | |
| Adverum Biotechnologies | 1.2 | $3.9M | 946k | 4.11 | |
| Intellia Therapeutics (NTLA) | 1.1 | $3.4M | 201k | 17.02 | |
| Chimerix (CMRX) | 1.0 | $3.3M | 598k | 5.54 | |
| Oncomed Pharmaceuticals | 0.9 | $3.0M | 266k | 11.43 | |
| Fate Therapeutics (FATE) | 0.6 | $1.8M | 591k | 3.12 | |
| Chemocentryx | 0.3 | $1.1M | 178k | 6.04 | |
| Syros Pharmaceuticals | 0.3 | $882k | 64k | 13.87 | |
| Cascadian Therapeutics Inc call | 0.1 | $170k | 104k | 1.64 |
